Pingda Ren, Ph.D.
Co-Founder, President/COO | Kumquat Biosciences Inc.
Professional Overview
Pingda Ren, Ph.D., is a seasoned biopharmaceutical executive with over 20 years of experience in drug discovery and development. As the Co-Founder, President, and Chief Operating Officer of Kumquat Biosciences Inc., he leverages his deep expertise in chemistry, pharmaceutical sciences, and operational leadership to drive the company's mission of developing innovative cancer therapeutics.
Experience Summary
Current Role
As the Co-Founder, President, and COO of Kumquat Biosciences, Dr. Ren is responsible for the overall strategic direction, operational management, and execution of the company's drug discovery and development programs. He oversees cross-functional teams in chemistry, biology, and pharmaceutical sciences to advance the company's pipeline of novel cancer treatments. Under his leadership, Kumquat Biosciences has established strategic partnerships and secured funding to accelerate its research and development efforts.
Career Progression
Prior to co-founding Kumquat Biosciences, Dr. Ren held key leadership roles at several successful biotech companies. He was the Co-Founder, Senior Vice President of Chemistry and Pharmaceutical Sciences at Kura Oncology, Inc., where he played a pivotal role in the company's growth and the advancement of its oncology pipeline. He also co-founded Araxes Pharma LLC and Wellspring Biosciences, contributing his expertise in chemistry and pharmaceutical sciences to drive the development of innovative cancer therapies.
Earlier in his career, Dr. Ren was a Co-Founder and Vice President of Chemistry at Intellikine, which was acquired by Takeda Pharmaceuticals. He also held research positions at GNF and AMRI, where he contributed to the discovery and development of small-molecule drug candidates.
Academic Background
Dr. Ren holds a Ph.D. in Organic Chemistry from the State University of New York at Buffalo, where he conducted postdoctoral research. His doctoral work focused on the synthesis and characterization of novel organic compounds, laying the foundation for his expertise in medicinal chemistry.
Areas of Expertise
- Medicinal and organic chemistry
- Pharmaceutical sciences and drug development
- Oncology drug discovery and pipeline advancement
- Cross-functional team leadership and operational management
- Strategic partnerships and business development
Professional Impact
Under Dr. Ren's leadership, Kumquat Biosciences has established a strong pipeline of oncology drug candidates and forged strategic collaborations with leading pharmaceutical companies. His contributions to the field of cancer research and drug development have been recognized through numerous publications and presentations at industry conferences.
Conclusion
With his extensive experience, technical expertise, and proven track record of success, Dr. Pingda Ren is a respected leader in the biopharmaceutical industry. As the Co-Founder, President, and COO of Kumquat Biosciences, he is poised to drive the company's continued growth and the development of transformative cancer therapies that positively impact patient lives.
